Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA060264-04
Application #
2100980
Study Section
Special Emphasis Panel (SRC (62))
Project Start
1993-06-01
Project End
1997-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Hanlon, A L; Watkins Bruner, D; Peter, R et al. (2001) Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys 49:51-9
Hanlon, A L; Hanks, G E (2000) Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 46:559-66
Hanks, G E; Hanlon, A L; Pinover, W H et al. (2000) Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46:823-32
Hanlon, A L; Hanks, G E (2000) Failure pattern implications following external beam irradiation of prostate cancer: long-term follow-up and indications of cure. Cancer J 6 Suppl 2:S193-7
Hanks, G E; Hanlon, A L; Pinover, W H et al. (1999) Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 5:152-8
Hanks, G E (1999) Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncol 38 Suppl 13:69-74
Hanks, G E (1998) Strategies for improving the outcome of patients with poor prognosis prostate cancers. Acta Oncol 37:5-9;discussion 3
Hanlon, A L; Hanks, G E (1998) Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer. Urology 52:735-8
Hanks, G E; Hanlon, A L; Schultheiss, T E et al. (1998) Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41:501-10
Hanlon, A L; Moore, D F; Hanks, G E (1998) Modeling postradiation prostate specific antigen level kinetics: predictors of rising postnadir slope suggest cure in men who remain biochemically free of prostate carcinoma. Cancer 83:130-4

Showing the most recent 10 out of 23 publications